KRTX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 72157 min ago

@ $329.82

Wydano: 15 kov. 2024 @ 17:55

Zwrot: 0.00%

Poprzedni sygnał: kov. 15 - 15:30

Poprzedni sygnał: Sprzedaż

Zwrot: -0.04 %

Live Chart Being Loaded With Signals

Commentary (15 kov. 2024 @ 22:00):

Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions...

Stats
Dzisiejszy wolumen	1.28M
Średni wolumen	971 825
Kapitalizacja rynkowa	12.60B
EPS	$0 ( 2024-05-02 )
Następna data zysków	( $0 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-28.09
ATR14	$4.03 (1.22%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-18	Wheadon David E.	Sell	990	Common Stock
2024-03-18	Wheadon David E.	Sell	25 000	Option (right to buy)
2024-03-18	Wheadon David E.	Sell	8 500	Option (right to buy)
2024-03-18	Wheadon David E.	Sell	5 000	Option (right to buy)
2024-03-18	Wheadon David E.	Sell	1 904	Option (right to buy)

INSIDER POWER
-93.83
Last 100 transactions
Buy: 115 486 \| Sell: 3 548 924

Wolumen Korelacja

Długi: 0.41 (neutral)

Krótki: 0.44 (neutral)

Signal:(75.401) Neutral

Karuna Therapeutics Inc Korelacja

10 Najbardziej pozytywne korelacje
MOR	0.975
META	0.974
ATCX	0.965
ECHO	0.959
IIN	0.957
TESS	0.955
NVCN	0.954
LIBY	0.952
TA	0.951
CGEM	0.951

10 Najbardziej negatywne korelacje
SGML	-0.972
REVB	-0.97
BIOL	-0.97
RVSB	-0.966
GOVX	-0.965
PRSO	-0.964
EXTR	-0.96
CHTR	-0.96
CYXT	-0.959
MRBK	-0.958

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Karuna Therapeutics Inc Korelacja - Waluta/Towar

0.57
( weak )

0.73
( moderate )

-0.28
( neutral )

0.41
( neutral )

-0.32
( neutral )

-0.63
( weak negative )

Karuna Therapeutics Inc Finanse

Annual	2023
Przychody:	$654 000
Zysk brutto:	$-1.05M (-160.09 %)
EPS:	$-11.73

FY	2023
Przychody:	$654 000
Zysk brutto:	$-1.05M (-160.09 %)
EPS:	$-11.73

FY	2022
Przychody:	$10.64M
Zysk brutto:	$9.53M (89.55 %)
EPS:	$-8.74

FY	2021
Przychody:	$36.96M
Zysk brutto:	$36.96M (100.00 %)
EPS:	$-5.44

Financial Reports:

No articles found.

Karuna Therapeutics Inc

Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients with schizophrenia; and for the treatment of central nervous system disorders, such as negative and cognitive symptoms of schizophrenia and psychosis, as well as for the treatment of dementia-related psychosis. The company also focuses on developing other muscarinic-targeted drug candidates. Karuna Therapeutics, Inc. has a license agreement with Eli Lilly and Company, and Zai Lab (Shanghai) Co., Ltd; patent license agreement with PureTech Health LLC; and drug discovery partnership with Charles River Laboratories, as well as drug discovery collaboration with PsychoGenics, Inc. The company was formerly known as Karuna Pharmaceuticals, Inc. and changed its name to Karuna Therapeutics, Inc. in March 2019. Karuna Therapeutics, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.